Seres Therapeutics
MCRB
#8831
Rank
โ‚น13.90 B
Marketcap
โ‚น1,537
Share price
-1.28%
Change (1 day)
1.83%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2025 (TTM): โ‚น1,183

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is โ‚น1,273. In 2024 the company made an earnings per share (EPS) of N/A an increase over its 2023 EPS that were of -โ‚น1,615.

EPS history for Seres Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1,183
2024N/A-100%
2023-โ‚น1,615-61.47%
2022-โ‚น4,192220.83%
2021-โ‚น1,307-35.71%
2020-โ‚น2,032-9.68%
2019-โ‚น2,250-48.97%
2018-โ‚น4,4109.95%
2017-โ‚น4,010-3.91%
2016-โ‚น4,174-1.29%
2015-โ‚น4,228285.48%
2014-โ‚น1,097157.99%
2013-โ‚น425.1642.44%
2012-โ‚น298.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
-โ‚น160.60-112.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
โ‚น1,033-18.82%๐Ÿ‡บ๐Ÿ‡ธ USA